Antiprogestin-releasing intrauterine devices: a novel approach to endometrial contraception

Contraception

Volumn 75, Issue 6 SUPPL., 2007, Pages

  Nayak, Nihar R ^a   Slayden, Ov D ^b   Mah, Kunie ^b   Chwalisz, Kristof ^c   Brenner, Robert M ^b  

^a STANFORD UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Women's Health   (United States)

Author keywords

Antiprogestins; Endometrial changes; Macaque monkeys; Progesterone withdrawal; Uterine bleeding

Indexed keywords

11BETA (4 ACETYLPHENYL) 17BETA HYDROXY 17ALPHA (1,1,2,2,2 PENTAFLUOROETHYL)ESTRA 4,9 DIEN 3 ONE; ANTIGESTAGEN; ESTRADIOL; STEROID RECEPTOR;

AMENORRHEA; ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL PROLIFERATION; CONTRACEPTION; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; INFERTILITY; INTRAUTERINE CONTRACEPTIVE DEVICE; LUTEAL PHASE; MACACA; MENSTRUATION; NONHUMAN; OVARIECTOMY; REVIEW; UTERINE BLEEDING PATTERN;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIUM; ESTRENES; FEMALE; INTRAUTERINE DEVICES, MEDICATED; MACACA NEMESTRINA; MENSTRUATION; PROGESTINS;

EID: 34248644857     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.01.024     Document Type: Review

References (25)

1. Ortiz M.E., Croxatto H.B., and Bardin C.W. Mechanisms of action of intrauterine devices. Obstet Gynecol Surv 51 Suppl (1996) S42-S51
2. Burton K.A., Henderson T.A., Hillier S.G., et al. Local levonorgestrel regulation of androgen receptor and 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrium. Hum Reprod 18 (2003) 2610-2617
3. Baird D.T., and Glasier A.F. RU 486 and other antiprogestins as Science, medicine, and the future. Contraception. BMJ 319 (1999) 969-972
4. Zelinski-Wooten M.B., Chwalisz K., Iliff S.A., Niemeyer C.L., et al. A chronic, low-dose regimen of the antiprogestin ZK 137 316 prevents pregnancy in rhesus monkeys. Hum Reprod 13 (1998) 2132-2138
5. Borman S.M., Schwinof K.M., Niemeyer C., Chwalisz K., Stouffer R.L., and Zelinski-Wooten M.B. Low-dose antiprogestin treatment prevents pregnancy in rhesus monkeys and is reversible after 1 year of treatment. Hum Reprod 18 (2003) 69-76
6. Grow D.R., Reece M.T., Hsiu J.G., et al. Chronic antiprogestin therapy produces a stable atrophic endometrium with decreased fibroblast growth factor: a 1-year primate study on contraception and amenorrhea. Fertil Steril 74 (2000) S70
7. Slayden O.D., Zelinski M.B., Chwalisz K., Hess-Stumpp H., and Brenner R.M. Chronic progesterone antagonist-estradiol therapy suppresses breakthrough bleeding and endometrial proliferation in a menopausal macaque model. Hum Reprod 21 (2006) 3081-3090
8. Slayden O.D., Chwalisz K., and Brenner R.M. Reversible suppression of menstruation with progesterone antagonists in rhesus macaques. Hum Reprod 16 (2001) 1562-1574
9. Fuhrmann U., Hess-Stumpp H., Cleve A., Neef G., Schwede W., Hoffmann J., et al. Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist. J Med Chem 43 (2000) 5010-5016
10. Slayden O.D., Zelinski-Wooten M.B., Chwalisz K., Stouffer R.L., and Brenner R.M. Chronic treatment of cycling rhesus monkeys with low doses of the antiprogestin ZK 137 316: morphometric assessment of the uterus and oviduct. Hum Reprod 13 (1998) 269-277
11. Brown A., Cheng L., Lin S., and Baird D.T. Daily low-dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: a double-blind randomized control trial of 2 and 5 mg per day for 120 days. J Clin Endocrinol Metab 87 (2002) 63-70
12. Cheng L., Zhu H., Wang A., Ren F., Chen J., and Glasier A. Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel. Hum Reprod 15 (2000) 1969-1972
13. Brenner R.M., and Slayden O.D. Progesterone receptor antagonists and the endometrial antiproliferative effect. Semin Reprod Med 23 (2005) 74-81
14. Chwalisz K., Brenner R.M., Fuhrmann U., Hess-Stumpp H., and Elger W. Antiproliferative effects of progesterone antagonists and progesterone receptor modulators (PRMs) on the endometrium. Steroids 65 (2000) 741-751
15. Brenner R.M., Slayden O.D., and Critchley H.O. Anti-proliferative effects of progesterone antagonists in the primate endometrium: a potential role for the androgen receptor. Reproduction 124 (2002) 167-172
16. Nayak N.R., Slayden O.D., Chwalisz K., Lehtinen M., and Brenner R.M. Antiprogestin-releasing intrauterine devices: A novel approach to endometrial contraception. Fertility and Sterility, 56th Annual Meeting of the American Society for Reproductive Medicine 74[3S] (2000) S70-S71 [Abstract]
17. Demers L.M., Macdonald G.J., Hertig A.T., King N.W., and MacKey J.J. The cervix uteri in Macaca mulatta, Macaca arctoides, and Macaca fascicularis - a comparative anatomic study with special reference to Macaca arctoides as a unique model for endometrial study. Fertil Steril 23 (1972) 529-534
18. Slayden O.D., Koji T., and Brenner R.M. Microwave stabilization enhances immunocytochemical detection of estrogen receptor in frozen sections of macaque oviduct. Endocrinology 136 (1995) 4012-4021
19. Slayden O.D., Hirst J.J., and Brenner R.M. Estrogen action in the reproductive tract of rhesus monkeys during antiprogestin treatment. Endocrinology 132 (1993) 1845-1856
20. Brenner R.M., and Slayden O.D. Steroid receptors in blood vessels of the rhesus macaque endometrium: a review. Arch Histol Cytol 67 (2004) 411-416
21. Lessey B.A., Killam A.P., Metzger D.A., Haney A.F., Greene G.L., and McCarty Jr. K.S. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab 67 (1988) 334-340
22. Neulen J., Williams R.F., Breckwoldt M., Chwalisz K., Baulieu E.E., and Hodgen G.D. Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms. Hum Reprod 11 (1996) 1533-1537
23. Slayden O.D., and Brenner R.M. Hormonal regulation and localization of estrogen, progestin and androgen receptors in the endometrium of nonhuman primates: effects of progesterone receptor antagonists. Arch Histol Cytol 67 (2004) 393-409
24. Grody M.H., Lampe E.H., and Masters W.H. Estrogen-androgen substitution therapy in the aged female. Obstet Gynecol 2 (1953) 36-45
25. Slayden O.D., and Brenner R.M. Flutamide counteracts the antiproliferative effects of antiprogestins in the primate endometrium. J Clin Endocrinol Metab 88 (2003) 946-949